Email Sign Up »
Receive Newsletters at Home »
Commentary from Dr. Daniel J. Wallace of the David Geffen School of Medicine at UCLA, and a founder of Lupus LA. Dr. Wallace was a top enroller of the two clinical trials of Benlysta.